Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review summarizing mechanisms, clinical progress, and therapeutic strategies for emerging immuno-oncology approaches in NSCLC, without original data or trial results.
This is a narrative review of emerging nanostructured materials for cancer applications; it raises mechanistic and design questions rather than reporting original experimental results or clinical outcomes.